Multicenter evaluation of efficacy and safety of low-dose versus high-dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients-Reference-Cited by-同舟云学术

Multicenter evaluation of efficacy and safety of low-dose versus high-dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients

Published:2016-11-07 Issue:6 Volume:18 Page:904-912
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Heldenbrand Seth¹²,Li Chenghui³,Cross Rosemary P.⁴,DePiero Kelly A.⁵,Dick Travis B.⁶,Ferguson Kara⁷,Kim Miae⁸⁹,Newkirk Erin¹⁰,Park Jeong M.¹¹¹²,Sudaria-Kerr Janice¹³,Tichy Eric M.¹⁴,Ueda Kimi R.¹⁵,Weng Renee¹⁶,Wisniewski Jesse¹³,Gabardi Steven⁹¹⁷¹⁸¹⁹

Affiliation:

1. Division of Transplant Surgery; University of Arkansas for Medical Sciences (UAMS); University Hospital; Little Rock AR USA

2. UAMS College of Pharmacy; Little Rock AR USA

3. Division of Pharmaceutical Evaluation and Policy; UAMS; Little Rock AR USA

4. Department of Transplant Services; Piedmont Hospital; Atlanta GA USA

5. Department of Pharmacy Services; Lahey Clinic Medical Center; Burlington MA USA

6. Department of Pharmacy Services; Intermountain Medical Center; Murray UT USA

7. Department of Pharmacy Services; UAMS; Little Rock AR USA

8. Department of Cardiology; Brigham and Women's Hospital (BWH); Boston MA USA

9. Pharmacy Services; BWH; Boston MA USA

10. Department of Pharmacy Services; Froedtert Hospital; Milwaukee WI USA

11. Department of Pharmacy Services; University of Michigan Health System; Ann Arbor MI USA

12. College of Pharmacy; University of Michigan; Ann Arbor MI USA

13. Department of Pharmacy Services; University of California San Diego Health System; San Diego CA USA

14. Department of Pharmacy Services; Yale New Haven Hospital; New Haven CT USA

15. Department of Pharmacy Services; California Pacific Medical Center; San Francisco CA USA

16. Department of Pharmacy Services; University of California Medical Center; Irvine CA USA

17. Department of Transplant Surgery; BWH; Boston MA USA

18. Renal Division; BWH; Boston MA USA

19. Harvard Medical School; Boston MA USA

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tid.12609/fullpdf

Reference33 articles.

1. Human cytomegalovirus and kidney transplantation: a clinician's update;De Keyzer;Am J Kidney Dis,2011

2. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation;Fisher;Transpl Infect Dis,2009

3. Revisiting the effects of CMV on long-term transplant outcome;Baron;Curr Opin Organ Transplant,2010

4. The effects of cytomegalovirus serology on graft and recipient survival in cadaveric renal transplantation: Implications for organ allocation;Schnitzler;Am J Kidney Dis,1997

5. CMV: prevention, diagnosis and therapy;Kotton;Am J Transplant,2013

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced dosing versus full dosing valganciclovir for prophylaxis of cytomegalovirus in high‐risk abdominal transplant recipients;Clinical Transplantation;2023-05-31

2. Impact of belatacept and tacrolimus on cytomegalovirus viral load control and relapse in moderate and high‐risk cytomegalovirus serostatus kidney transplant recipients;Transplant Infectious Disease;2022-11-14

3. Prophylaxis of Cytomegalovirus Infection in Solid Organ Transplantation, Retrospective Evaluation;Transplant Research and Risk Management;2022-06

4. Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center;Transplant Infectious Disease;2022-06

5. Low-Dose Valganciclovir Prophylaxis Is Safe and Cost-Saving in CMV-Seropositive Kidney Transplant Recipients;Progress in Transplantation;2021-11-27